Staphylococcus aureus iron-regulated surface protein A (IsdA) is a fibrinogen and fibronectin adhesin that also contributes to iron sequestration and resistance to innate immunity. IsdA is conserved in human isolates and has been investigated as a human vaccine candidate. Here we report the expression of isdA, the efficacy of anti-IsdA responses and the existence of IsdA sequence variants from bovine Staphylococcus. Clinical staphylococci were obtained from US dairy farms and assayed by PCR for the presence and expression of isdA. isdA-positive species from bovines included S. aureus, S. haemolyticus and S. chromogenes. Immunoassays on bovine milk and serum confirmed the induction and opsonophagocytic activity of anti-IsdA humoral responses. The variable region of isdA was sequenced and protein alignments predicted the presence of two main variants consistent with those from human S. aureus. Mouse antibodies against one IsdA variant reduced staphylococcal binding to fibronectin in vitro in an isotype-dependent manner. Purified IsdA variants bound distinctly to fibronectin and fibrinogen. Our findings demonstrate that variability within the C-terminus of this adhesin affects immune reactivity and binding specificity, but are consistent with the significance of IsdA in bovine disease and relevant for vaccine development.
INTRODUCTION
Bovine mastitis is an inflammatory condition of the udder and regarded as one the most important diseases affecting dairy cattle worldwide. Multiple pathogens are capable of colonizing the udder; however, infection caused by Staphylococcus aureus is among the most relevant and economically impactful, resulting in clinical or subclinical disease that affects milk yield and somatic cell count (SCC) (Barkema, Schukken and Zadoks 2006; Bar et al. 2008; De Vliegher et al. 2012; Haran et al. 2012 ). Antibiotic therapy is often ineffective, and longitudinal transmission of resistant strains is an increasing concern with implications for veterinary and public health. While efforts have focused on management practices, an effective S. aureus vaccine for dairy heifers would improve animal health, increase milk production and reduce agricultural dependence on antibiotics. Vaccine strategies must include conserved virulence determinants and account for antigen sequence variation.
The S. aureus iron-regulated surface determinant A (IsdA) is a fibrinogen (FG) and fibronectin (FN) adhesin that contributes to iron sequestration and the characteristic ability of S. aureus to disseminate (Clarke, Wiltshire and Foster 2004; Torres et al. 2006) . The presence of IsdA is conserved among human isolates of S. aureus, and studies have described IsdA as a central human vaccine candidate (Clarke et al. 2006; Stranger-Jones, Bae and Schneewind 2006; Kim et al. 2010; Arlian and Tinker 2011; Stapleton et al. 2012) . Full-length isdA is present in the bovine strain Newbould 305, as well as 100% of S. aureus isolates causing mastitis in ruminants from an international genotyping effort (Wolf et al. 2011; Bar-Gal et al. 2015) . IsdA is also expressed at higher levels in strains more likely to cause mastitis in ruminants (Le Marechal, Hernandez and Schrenzel 2011) . Staphylococcus aureus utilizes the Isd system, which is composed of IsdA and at least four additional cell-wall-anchored proteins (IsdB, C, H and I), to chelate iron from host heme. Each of these proteins contains conserved stretches of 125 amino acids called the near-iron transporter (NEAT) domain to bind heme for transport to the cytosol and iron-scavenging (Hammer and Skaar 2011) . IsdA is also a physiologically relevant extracellular matrix (ECM) adhesin to FG and FN that promotes binding to epithelial cells, and is required for colonization of rat nares (Clarke, Wiltshire and Foster 2004; Clarke et al. 2006 Clarke et al. , 2009 Corrigan, Miajlovic and Foster 2009 ). The FG-binding site lies within the NEAT domain; however, the function of the IsdA C-terminus is less well understood. A cell-wall-binding (LPxGT) motif is present, and the C-terminus is involved in surface hydrophobicity that confers resistance to fatty acids and antimicrobial peptides, such that IsdA is required for growth on human skin (Clarke et al. 2007 ). These reports indicate that IsdA is an important S. aureus virulence factor that may contribute to infection of the bovine udder.
The aim of the current study was to confirm the presence and expression of isdA from bovine isolates of staphylococci as well as the efficacy of anti-IsdA responses. In addition, we identified isdA allelic variants that affect immune reactivity and binding specificity. These findings support the incorporation of IsdA into a multicomponent S. aureus bovine vaccine but acknowledge that sequence variation will be an important consideration.
MATERIALS AND METHODS

Bovine milk, serum and staphylococcal collection
Blood and quarter milk were taken from observationally healthy lactating Holstein cows from Dairy 1 (D1; n = 53) and Dairy 2 (D2; n = 50) in the Northwest USA. All bovine sample collection protocols were pre-approved by the University of Idaho Institutional Animal Care and Use Committee (IACUC). SCCs were determined using the Delaval method (Tumba, Sweden). Milk (100 μl) was plated on mannitol salt agar (MSA) and MP2 Agar (Udder Health Systems Inc., Tacoma WA, USA) and cultured at 37
• C for 24 h. Samples with yellow growth on MSA plus growth in the absence of esculin hydrolysis on MP2 were presumptive staphylococci ( 
RT-PCR, ELISA, western and opsonophagocytosis
Total RNA was isolated from milk as described (Mura et al. 2013) . Briefly, milk was centrifuged at 3000 × g for 15 min at 4
• C and pellets washed (1× PBS + 0.5 mM EDTA). RNA was extracted (RNeasy, Qiagen), with an additional DNase (Promega, Madison, WI) treatment (1U/100 μL, 30 min). cDNA was transcribed as described by the manufacturer (High Capacity cDNA RT kit, Thermo Fisher) and included no RT controls. 16S rRNA and isdA PCR were conducted on 2 μL of cDNA with primers (Table 1) and GAPDH control. PCR (15 μL) was analyzed on 1% agarose with positive (Newbould 305) and negative (no template). For milk and serum ELISA, a HIS-IsdA fusion (pBA015, Table 1 ) was purified with cobalt chromatography as described (Arlian and Tinker 2011) . Plates (Nunc, Thermo-Fisher) were coated with 50 μL of 10 μg/mL IsdA, and incubated for 12 h at 4
• C followed by washes (1× PBS + 0.05% Tween 20). Blocking buffer (1× PBS + 1% skim goat milk) was added for 2 h at 37
tions, starting at 1:2 for milk and 1:10 for serum, were added and incubated at 4
• C for 12 h prior to washing and addition of HRP-anti-bovine IgG (1:10,000 Bethyl Laboratories, Montgomery, TX, USA). Samples were developed with tetramethylbenzidine (TMB One, Thermo-Fisher). Endpoint titers were defined as the reciprocal of the dilution giving an OD of 0.2. Staphylococcus + and isdA ± cows used in ELISA are shown (Table S1 , Supporting Information). Ten cows from each farm, with both high and low SCC, and negative for Staphylococcus by culture, were also assayed (Staphylococcus-isdA-). ELISAs are by quarter for milk and by cow for blood. For westerns, IsdA (pBA015, 62 kD) was separated on 12% SDS-PAGE, transferred to nitrocellulose strips and incubated in blocking buffer (0.05% Tween-20 + 5% skim milk + 1× PBS) before probing with milk at 1:500. HRP-antibovine IgG (1:5000 Bethyl Labs, Montgomery, TX) was added and strips were developed with Immobilon Western HRP substrate (Millipore, Billerica, MA, USA). Opsonophagocytosis (OSP) was performed as described (Kurokawa et al. 2013 ) with the addition of purified IsdA. IsdA (pCK001) was purified using cobalt as above for pBA015. Equal volumes of 50 μg heat-inactivated serum were mixed with 50 μg purified IsdA and incubated for 1 h at 37
Equal volumes of S. aureus Newbould 305 (2 × 10 6 ) and bovine PBMCs (2 × 10 6 ) were added to the reaction and incubated at 37
• C. At 60 min, cells were plated on MSA in triplicate. Results are reported as bacterial survival in CFU/mL and compared to survival without PBMCs.
Sequence alignments and predicted tertiary structure
The variable region of IsdA was predicted to comprise amino acids 222-308 (NCBI). Primers that encompass this region were used for isdA PCR and sequencing (GE Healthcare). Alignments and evolutionary analysis were completed in MEGA 7 (Kumar, Stecher and Tamura 2016). A rooted dendrogram of exhaustive pairwise IsdA alignments of 53 sequences (Table S2 , Supporting Information) was constructed using maximum likelihood based on the JTT matrix-based model (Jones, Taylor and Thornton 1992) . The I-TASSER server was used to visualize predicted IsdA tertiary structures (Yang et al. 2015) . Model templates included the S. aureus hemoglobin-IsdH complex and the NEAT domain of IsdA from S. aureus (Grigg et al. 2007; Grigg, Mao and Murphy 2011; Honsa et al. 2013; Dickson et al. 2014) . The Newbould 305 model has a C score of -1.93 (estimated TM score of 0.48 ± 0.15), and the MRSA252 model has a C score of -2.46 (estimated TM score of 0.43 ± 0.14). In the I-TASSER server, the range of C scores is -5 to 2, with >-1.5 indicating correct global topology.
Anti-IsdA mouse serum
Mouse immunization protocols were pre-approved by the Boise State University IACUC. Immunizations were performed as described (Arlian and Tinker 2011) . Briefly, two groups of six female BALB/c mice, 7 to 9 weeks old (Taconic, Hudson, NY), were administered 17 μg purified IsdA (MRSA252 variant III, pBA009) + 5 μg native cholera toxin (CT, Sigma Aldrich, St. Louis, MO, USA), or mock (PBS) in 10 μL 1XPBS applied to each nare by pipette under light anesthesia on days 0 and 10. Blood samples were obtained by lateral tail vein on day 14. Blood was allowed to coagulate and serum diluted 10-fold in protease inhibitor (as above). IsdA-specific antibodies in serum were analyzed by ELISA as described and endpoint titers defined as the reciprocal of the dilution giving an O.D. of 0.2 (Arlian and Tinker 2011).
Adhesion blocking and ECM binding assays
For blocking assays, black walled (Nunc, Thermo-Fisher) 96-well plates were coated with 50 μL of 10 μg/mL bovine FN (R&D Systems, Minneapolis, MN, USA) for 12 h at 4
• C. A 1:100 dilution of heat inactivated pooled mouse serum was mixed with 1 × 10 8 CFU of S. aureus MRSA252 or Newbould 305, grown in low iron media (LIM: 2 g NaCl, 1.2 g NaHCO 3 , 1.6 g yeast extract, 6 g proteose peptone/400 mL), for 30 min at 37 • C. A portion of 100 μL of the mixture was added to plates coated with FN and incubated at 37
• C for 12 h prior to washing and addition of 150 μL Alamar Blue (0.1% reazzurin in 1× PBS). Plates were read at 530/590 nm after 24 h. For binding assays, IsdA from pBA009A and pCK001 was purified as above and separated on 12% SDS-PAGE. Purified IsdA (100 μg) was added in 2-fold dilutions to 96-well plates coated with 10 μg/mL bovine FN or bovine FG (Alfa Aerar, Reston, VA, USA) and incubated at 37
• C for 12 h prior to washing and addition of mouse anti-HIS (1:1000 Sigma) and anti-mouse HRP secondary (1:10 000 Promega). Plates were developed (TMB One) and read at 370 nm.
Graphing and statistical analysis
Graphing and statistical analysis was performed with JMP SAS software (Cary, NC, USA). PCR and RT-PCR are representative of three independent assays; ELISAs are reported as the means of three independent assays; and the OSP, adhesion and FN/FG binding assays are triplicate means of one assay that is representative of three independent assays. Significance for ELISA 
RESULTS
Presence and expression of isdA in bovine isolates of staphylococci
Blood and milk were obtained from 103 cows at two US dairies that differed in size and operation. Presumptive staphylococci from milk were assayed by PCR for the presence of isdA and 16S rRNA species identification. Four isolates of 34 (12%) were Staphylococcus aureus and 19 were isdA positive (56%). Twenty-five additional clinical bovine S. aureus isolates were obtained. The presence of isdA, and six additional virulence factors, was assessed by PCR in all staphylococci (Table 2) . isdA was conserved in S. aureus (total of 28/29, 96.6%), and also present in S. haemolyticus (11/17, 64.7%), S. chromogenes (2/5, 40%) and S. devreise (1/1, 100%). isdB was conserved in all S. aureus (29/29, 100%), and other species harboring isdA. The adhesin clumping factor A (clfA) was also highly conserved (28/29, 96.6%).
To determine the expression of isdA during mammary infection, we identified the presence of isdA mRNA from total milk RNA. As shown in Fig. 1A , the majority of isdApositive staphylococci-infected milk samples (Staphylococcus+ isdA+) contained isdA mRNA. The staphylococcal culture from 14FL (D1) was negative for isdA by PCR, and the milk sample was negative by RT-PCR. Two Staphylococcus+isdA+ samples had low CFUs, and were inconclusive by RT-PCR (D1-26FR and D2-43FL). The expression of IsdA in vivo was assessed by antiIsdA ELISA of milk and serum. As shown in Fig. 1B and C, Staphylococcus+ isdA+ milk and serum samples had heightened anti-IsdA IgG responses over samples negative for Staphylococcus (Staphylococcus-isdA-) . A western blot of purified IsdA probed with Staphylococcus+ isdA+ milk (cows D2 43FR and D2 37FR) compared to Staphylococcus -isdA -milk (cows D2 1FL and D2 6FL) supported the immunogenicity of IsdA in vivo (Fig. 1D) . To assess the efficacy of anti-IsdA serum antibodies, we determined OSP of S. aureus Newbould 305 (Fig. 1E) . Bacterial cells were mixed with bovine PBMCs and Staphylococcus-isdA-serum (low antiIsdA titer, light gray bars) or Staphylococcus+isdA+ serum (high anti-IsdA titer, dark gray bars). Serum was preincubated in the presence or absence of purified IsdA to block antibody activity. High anti-IsdA serum stimulated more bacterial killing than low anti-IsdA serum (P ≤ 0.05), and purified IsdA significantly blocked bacterial killing in the presence of high anti-IsdA serum (P ≤ 000.1).
IsdA sequence analysis
Comparison of published S. aureus IsdA indicates that 86 amino acids within the C-terminus are variable. This region is distinct from conserved iron-binding, heme-binding and NEAT domains of IsdA, as well as the C-terminal cell wall sortase signal (Fig. 2A) . The 380-bp variable region from all isdA+ staphylococcal isolates was amplified for sequencing and alignment. Figure 2 shows IsdA alignments from staphylococci of the two dairies (B) and 23 S. aureus clinical isolates (C). One S. aureus was negative for isdA by PCR and one was isdA+ but sequence could not be obtained. Nucleotide differences within this region resulted in two main allelic variants that align with bovine (Newbould 305, variant I) and human (MRSA252, variant III) IsdA. Notably, variant III contains a characteristic four-amino-acid insertion near the C-terminus. Predicted tertiary structure models were constructed using IsdA from Newbould 305 and MRSA252 (Fig. 2D ) (Yang et al. 2015) . Models predict that the variable region of IsdA has a coiled secondary structure with a solvent accessibility of 3-7 (0 = buried residue, 9 = highly exposed).
To determine if observed variation is consistent with human S. aureus IsdA, phylogenetic analysis was completed with 53 published sequences (Fig. 3) . Results included four cow, four pig and one chicken isolate. Sequences were largely conserved; however, differences within the variable region resulted in clustering within two groups represented by MRSA252 (III, blue) and Newbould 305 (I, red). A smaller subgroup consisted of those that contained only the characteristic four-amino-acid C-terminal insertion (variant II, green). Two strains (CA-347 and SK1585) are closely related to variant II, but do not contain this C-terminal insertion.
Characterization of IsdA variants
To assess if genetic variation of isdA could contribute to differences in protein immune reactivity, we produced antibodies to variant III (MRSA252) in mice (Fig. 4A ) and used pooled serum to block S. aureus adhesion to FN. Antibodies produced against variant III reduced FN binding of S. aureus MRSA252, but did not reduce binding of Newbould 305 (Fig. 4B) . Variants I and III were purified from Escherichia coli and found to run at distinct sizes on SDS-PAGE (Fig. 4C) . ECM binding assays revealed that variant I (Newbould 305) and variant III (MRSA252) had consistently distinct interactions with FN, while variants bound similarly to FG ( Fig. 4D and E) .
DISCUSSION
Despite much research on the pathogenesis of Staphylococcus aureus, this bacterium remains an elusive target for prevention.
The current study was undertaken to evaluate IsdA expression and sequence variation to inform bovine vaccine development. The presence of isdA was found to be conserved in bovine S. aureus. We also observed isdA in bovine coagulase negative staphylococci. While these species tend to produce less severe disease than S. aureus, they are often associated with mastitis and clinically relevant (Waller et al. 2011) . The presence of isdB and clfA was also conserved. Previous reports suggest that IsdB is not a viable vaccine antigen but ClfA could be further evaluated for a role in bovine disease (Fowler et al. 2013) . Our findings that isdA mRNA is expressed, and anti-IsdA is induced in milk and serum, indicate that this protein is surface exposed during infection. Additionally, OSP assays provide evidence that IsdA antibodies are able to trigger antigen uptake and effective S. aureus killing. The predicted sequence of IsdA revealed polymorphisms within the C-terminus, and two main allelic variants. While variation may be more extensive than our limited sample size and geographic area reveals, the identified sequences correspond to published bovine (I, Newbould 305) and human (III, MRSA252) strains, with variant I predominating from both hosts. Most substitutions within the variable region of IsdA are conserved; however, the four-amino-acid insertion and a proline to histidine substitution at amino acid 303 are not. These changes affect IsdA immune reactivity as well as binding specificity. The function of the C-terminal region of IsdA is reported to decrease bacterial hydrophobicity to support human skin colonization (Clarke et al. 2007) . Our results are consistent with the additional involvement of this region in FN binding, with FG binding occurring within the NEAT domain as reported (Clarke, Wiltshire and Foster 2004; Clarke et al. 2007 ). While our sampling does not support the conclusion that IsdA allelic variants are specific to host, or to species, they indicate a significant role for this adhesin in host interaction and bovine disease. Sequence variation will require further consideration; however, these results support the continued exploration of IsdA as an antigenic target for bovine vaccines.
